Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management

Circulating tumoral DNA (ctDNA), commonly named “liquid biopsy”, has emerged as a new promising noninvasive tool to detect biomarker in several cancers including lung cancer. Applications involving molecular analysis of ctDNA in lung cancer have increased and encompass diagnosis, response to treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrell, Julie A., Mau-Them, Frédéric Tran, Béganton, Benoît, Godreuil, Sylvain, Coopman, Peter, Solassol, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343800/
https://www.ncbi.nlm.nih.gov/pubmed/28146051
http://dx.doi.org/10.3390/ijms18020264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343800/
https://www.ncbi.nlm.nih.gov/pubmed/28146051
http://dx.doi.org/10.3390/ijms18020264

Ejemplares similares